Source link : https://www.newshealth.biz/health-news/fda-clears-first-1-year-continuous-glucose-sensor/
The US Food and Drug Administration (FDA) has cleared the Eversense 365 (Senseonics), an implanted continuous glucose monitoring (CGM) system that lasts a year. The Eversense is inserted subcutaneously into the upper arm by a certified healthcare professional during a brief office procedure. The transmitter is placed on the skin on top of the implanted […]
Author : News Health
Publish date : 2024-09-17 18:41:58
Copyright for syndicated content belongs to the linked Source.